Trexquant Investment’s ChemoCentryx, Inc. CCXI Stock Holding History

Trexquant Investment’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,024	Closed	-$878K	–	1990
2022 Q1	$878K	Sell	35,024 -4,841	-12%	-$136K	0.04%	523
2021 Q4	$1.45M	Buy	+39,865	New	+$1.4M	0.09%	284
2020 Q3	–	Sell	-10,966	Closed	-$631K	–	1628
2020 Q2	$631K	Sell	10,966 -4,119	-27%	-$224K	0.04%	582
2020 Q1	$606K	Buy	+15,085	New	+$641K	0.04%	599
2019 Q3	–	Sell	-14,327	Closed	-$133K	–	1193
2019 Q2	$133K	Buy	+14,327	New	+$166K	0.01%	727
2019 Q1	–	Sell	-33,717	Closed	-$368K	–	1409
2018 Q4	$368K	Buy	+33,717	New	+$356K	0.02%	714
2018 Q3	–	Sell	-17,056	Closed	-$225K	–	1273
2018 Q2	$225K	Buy	17,056 +5,482	+47%	+$65.6K	0.02%	758
2018 Q1	$157K	Sell	11,574 -27,011	-70%	-$279K	0.01%	975
2017 Q4	$230K	Buy	+38,585	New	+$265K	0.03%	870
2017 Q3	–	Sell	-18,600	Closed	-$174K	–	1103
2017 Q2	$174K	Buy	18,600 +8,327	+81%	+$61.1K	0.05%	692
2017 Q1	$75K	Buy	+10,273	New	+$74K	0.01%	1040

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Trexquant Investment's CCXI Position: Q2 2022 in Review

Trexquant Investment sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 35,024 shares — an estimated $878K sold.

Trexquant Investment first reported a position in CCXI in Q1 2017 and held it in 11 quarters. The position peaked at $1.45M in Q4 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

Trexquant Investment reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
Trexquant Investment sold 35,024 ChemoCentryx, Inc. shares in Q2 2022, an estimated $878K.
Trexquant Investment first reported a position in ChemoCentryx, Inc. in Q1 2017 and held it in 11 quarters.
Trexquant Investment's ChemoCentryx, Inc. position peaked at $1.45M in Q4 2021.
182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on Trexquant Investment's 13F filing for Q2 2022, filed 11 Aug 2022.